Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Reexamination Certificate
2006-06-27
2006-06-27
Campell, Bruce R. (Department: 1654)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
C514S002600, C530S324000
Reexamination Certificate
active
07067486
ABSTRACT:
The invention relates to a cell growth and/or differentiation regulatory peptide comprising a sequence of about 9 to about 150 amino acids derived from acetylcholinesterase amino acid sequence, preferably from the C-terminal region of acetylcholinesterase. The invention also relates to pharmaceutical compositions comprising the peptides, particularly for use in promoting survival of stem cells, promoting differentiation of stem cells, promoting growth of stem cells and/or promoting the growth-enhancing effect of a growth factor on stem cells, alone, or in combination with other growth factors. Of particular interest is the use of the peptides in the treatment of thrombocytopenia, post-irradiation conditions, post-chemotherapy conditions, or conditions following massive blood loss and promotion of neural progenitors in use for cell therapies aimed at restoring neural functions in diseased individuals. Further, the invention relates to antibodies against the peptides, inter alia for diagnostic use, for example, the diagnosis of stress-induced male infertility. The invention also relates to in vitro and in vivo methods for screening of drugs that affect the central nervous system, and are potential modulators of interactions between the “readthrough” form of acteylcholinesterase, AChE-R, the intracellular receptor RACK1 and the kinase PKC.
REFERENCES:
patent: 6258780 (2001-07-01), Soreq et al.
patent: WO9108302 (1991-06-01), None
patent: WO9822132 (1998-05-01), None
A. Deutch et al., ARP—a novel hematopoietic growth factor and stress signal derived from acetylcholinesterase,Blood, 94:46A (Abstract 193, poster session 193-I) (1999).
M.A.R. Ibrahim and J. Gaál, Effects fo Seminal Plasma Cholinesterase on the Viability and Freezing Properties of Bull Spermatozoa,Acta Vererinaria Academia Scientarium Hungaricae, 27(4):403-407 (1979).
N. Perdon, Choliensterase Activity of Semical Plasma and Human Spermatozoa in Normal and Infertile Subjects,Arch. Androl., 10(3):249-251 (1980).
J.-M Pallus et al., Mouse Megakaryocytes Secrete Acetylcholinesterase,Blood, 58:1100-1106 (1981).
M. Sternfield et al., Acetylcholinesterase Enhances Neurite Growth and Synapse Development Through Alternative Contributions of its Hydrolitic Capacity, Core Protein, and Variable C. Termini,J. Neurosci., 18(4):1240-1249 (1998).
T. Battaini et al., Protein Kinase C Anchoring Deficit in Postmortem Brains of Alzheimer's Disease Patients,Exp Neurol, 159:559-564 (1999).
M. Cardell and T. Wieloch, Time Course of the Translocation and Inhibition of Protein Kinase C During Complete Cerebral Ischemia in the Rat,J Neurochem, 61:1308-1314 (1993).
B. Y. Chang et al., RACK1, a Receptor for Activated C Kinase and a Homology of the β Subunit of G Proteins, Inhibits Activity of Src Tyrosine Kinases and Growth of NIH 3T3 Cells,Mol Cell Biol, 18:3245-3256 (1998).
M. Davis et al., Neurotransmission in the rat amygdale related to fear and anxiety,Trends Neurosci, 17:208-214 (1994).
M. Disatnik et al., Phospholipase C-γ1 binding to intracellular receptors for activated protein kinase C,Proc Natl Acad Sci USA, 91:559-563 (1994).
G. I. Gallicano et al., PKC—a pivotal regulator of early development,Bioassay, 19:29-36 (1997).
J. Gorman et al., Neuronanatomical Hypothesis of Panic Disorder, Revised,Am J Psychiatry, 157:493-505 (2000).
M. Grifman et al., Functional redundancy of acetylcholinesterase and neuroligin in mammalian neuritogenesis,Proc Natl Acad Sci USA, 95:13935-13940 (1998).
J. P. Herman and W. E. Cullinan, Neurocircuitry if stress: central control of the hypothalamo-pituitary-adrenocortical axis,Trends Neurosci, 20:78-84 (1997).
D. A. Hoffman and D. Johnston, Downregulation of Transient K+Channels in Dendrites of Hippocampal CA1 Pyramidal Neurons by Activation of PKA and PKC,J Neurosci, 18:3521-3528 (1998).
J. Liliental and D. D. Chang, Rack1, a Receptor for Activated Protein Kinase C, Interacts with Integrin β Subunit ,J Biol Chem, 273:2379-2389 (1998).
R. K. McNamara et al., Differential Subcellar Redistribution of Protein Kinase C Isozymes in the Rat Hippocampus Induced by Kainic Acid,J Neurochem, 72:1735-1743 (1999).
D. Paola et al., Oxidative Stress Induced Increase in Intracellular Amyloid β-Protein Production and Selective Activation of βI and βII PKCs in NT2 Cells,Biochem Biophys Res Commun, 268:642-646 (2000).
E.D. Roberson et al., The Mitogen-Activated Protein Kinase Cascade Copules PKA and PKC to cAMP Response Element Binding Protein Phosphorylation in Area CA1 and Hippocampus,J Neurosci, 19:4337-4348 (1999).
M. M. Rodriguez et al., RACK1, a Protein Kinase C Anchoring Protein, Coordinates of Binding of Activated Protein Kinase C and Select Pleckstrin Homology Domains in Vitro,Biochemistry, 38:13787-13794 (1999).
D. Ron et al., Coordinated movement of RACK1 with Activated βIIPKC,J. Biol Chem, 274:27039-27046 (1999).
F. Tronche et al., Disruption of the glucocorticoid receptor gene in the nervous system results in reduced anxiety,Nat Genet, 23:99-103.
W. J. Weeber et al., A Role for the β Isoform of Protein Kinase C in Fear Conditioning,J Neurosci, 20:5906-5914 (2000).
L. Xu et al., Behavioural stress facilitates the induction of long-term depression in the hippocampus,Nature, 387:497-500 (1997).
S. J. Yarwood et al., The RACK1 Signaling Scaffold Protein Selectively Interacts with the cAMP-specific Phosphodiesterase PDE4D5 Isoform,J Biol Chem, 274:14909-14917 (1999).
Deutch Varda
Eldor, legal representative Sofia
Grisaru Dan
Soreq Hermona
Campell Bruce R.
Chism B. Dell
Cooper & Dunham LLP
White, Esq. John P.
Yissum Research Development Company of the Hebrew University of
LandOfFree
Acetylcholinesterase-derived peptides and uses thereof does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Acetylcholinesterase-derived peptides and uses thereof, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Acetylcholinesterase-derived peptides and uses thereof will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3649731